|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,250.00 KRW | -20.63% |
|
-0.00% | -0.00% |
| 25-04-06 | Celestra Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 25-03-17 | Clinomics Inc. announced that it has received KRW 5.5 billion in funding | CI |
| Market Cap | 13.41B 9.33M 8.07M 7.52M 6.9M 13.03M 890M 13.23M 88.57M 34.72M 443M 35.04M 34.28M 1.47B | P/E 2024 |
-0.4x | P/E 2025 | -1.14x |
|---|---|---|---|---|---|
| Enterprise Value | 17.19B 11.97M 10.35M 9.64M 8.85M 16.71M 1.14B 16.97M 114M 44.53M 568M 44.94M 43.96M 1.88B | EV / Sales 2024 |
5.8x | EV / Sales 2025 | 8.56x |
| Free-Float |
78.31% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -20.63% | ||
| 1 week | -0.00% | ||
| Current month | -0.00% | ||
| 1 month | -0.00% | ||
| 3 months | -0.00% | ||
| 6 months | -0.00% | ||
| Current year | -0.00% |
| 3 years | 4,245 | 63,000 | |
| 5 years | 4,245 | 145,500 | |
| 10 years | 4,245 | 261,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seo-Hyeon Baek
CEO | Chief Executive Officer | 30 | 2024-03-28 |
Jong-Bin Baek
AUD | Comptroller/Controller/Auditor | 47 | 2025-03-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Seo-Hyeon Baek
BRD | Director/Board Member | 30 | 2024-03-28 |
Hoo-Hyuk Hong
BRD | Director/Board Member | 42 | 2025-09-24 |
Young-Il Yoo
BRD | Director/Board Member | 41 | 2024-06-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/17/24 | Sell | Chief Executive Officer | 100,000 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -20.63% | -0.00% | -0.00% | -88.78% | 9.33M | ||
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | ||
| -2.41% | -0.90% | +411.96% | +495.33% | 39.87B | ||
| -1.16% | +12.96% | +28.81% | +7.25% | 38.68B | ||
| -1.88% | -3.03% | +5.69% | +53.00% | 35.13B | ||
| -1.74% | +5.12% | +14.44% | +41.77% | 29.79B | ||
| -0.21% | -4.04% | +36.40% | +125.75% | 16.11B | ||
| -2.85% | -3.92% | - | - | 16.08B | ||
| -0.64% | +2.65% | +3.40% | +13.11% | 13.61B | ||
| -1.19% | -1.32% | -1.73% | -34.37% | 12.62B | ||
| Average | -3.41% | -2.44% | +55.25% | +69.37% | 25.04B | |
| Weighted average by Cap. | -1.60% | +2.03% | +79.78% | +108.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.5B 5.92M 5.12M 4.77M 4.38M 8.26M 565M 8.39M 56.17M 22.02M 281M 22.22M 21.74M 930M | 2.01B 1.4M 1.21M 1.13M 1.03M 1.95M 133M 1.98M 13.27M 5.2M 66.38M 5.25M 5.13M 220M |
| Net income | -46.92B -32.66M -28.25M -26.32M -24.17M -45.61M -3.12B -46.31M -310M -122M -1.55B -123M -120M -5.14B | -11.77B -8.19M -7.09M -6.6M -6.06M -11.44M -782M -11.62M -77.77M -30.49M -389M -30.77M -30.1M -1.29B |
| Net Debt | 29.34B 20.42M 17.66M 16.46M 15.11M 28.52M 1.95B 28.96M 194M 75.99M 970M 76.69M 75.02M 3.21B | 3.79B 2.63M 2.28M 2.12M 1.95M 3.68M 251M 3.74M 25.01M 9.8M 125M 9.89M 9.68M 414M |
Employees
48
- Stock Market
- Stocks
- A352770 Stock
Select your edition
All financial news and data tailored to specific country editions
















